Breast cancer genes and the pill reduce cancer riskBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7157.489 (Published 22 August 1998) Cite this as: BMJ 1998;317:489
- Scott Gottlieb
- New York
The regular use of oral contraceptives seems to halve the chance of developing ovarian cancer among women who inherit BRCA1 and BRCA2, two faulty genes that put them at high risk for the disease.
Doctors have known for years that oral contraceptives reduce the risk of ovarian cancer by as much as half among women in general. The new study examined whether those benefits extend to women whose risk resulted from inheriting BRCA1 and BRCA2. While …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial